We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

56 hedge funds and large institutions have $59.1M invested in Windtree Therapeutics Inc in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more call options, than puts

Call options by funds: $427K | Put options by funds: $204K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 62 → 56 (-6)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

37% less capital invested

Capital invested by funds: $93.8M → $59.1M (-$34.7M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
56
Holders Change
-6
Holders Change %
-9.68%
% of All Funds
1.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
12
Reduced
14
Closed
13
Calls
$427K
Puts
$204K
Net Calls
+$223K
Net Calls Change
+$263K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$940K
2
TI
Turner Investments
Pennsylvania
+$357K
3
Morgan Stanley
Morgan Stanley
New York
+$345K
4
CS
Credit Suisse
Switzerland
+$160K
5
OAM
Oxford Asset Management
United Kingdom
+$156K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$893K
2
NC
Northpointe Capital
Michigan
-$615K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$256K
4
NIP
Nicholas Investment Partners
California
-$189K
5
Deutsche Bank
Deutsche Bank
Germany
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$69K +$93.9K +4,271 New
State Street
27
State Street
Massachusetts
$60K -$9.28K -422 -10%
FSA
28
Franklin Street Advisors
North Carolina
$52K – – –
BAM
29
Brave Asset Management
New Jersey
$48K -$3.14K -143 -5%
T. Rowe Price Associates
30
T. Rowe Price Associates
Maryland
$42K – – –
Group One Trading
31
Group One Trading
Illinois
$38K -$73.1K -3,325 -59%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$31K – – –
WSCM
33
Wellington Shields Capital Management
New York
$29K – – –
BA
34
BlackRock Advisors
Delaware
$26K – – –
Stifel Financial
35
Stifel Financial
Missouri
$26K +$8.64K +393 +32%
Citadel Advisors
36
Citadel Advisors
Florida
$24K -$5.83K -265 -15%
FAAS
37
First Allied Advisory Services
California
$24K – – –
RFC
38
Regions Financial Corp
Alabama
$23K – – –
PAG
39
Pinnacle Advisory Group
Maryland
$21K +$3.98K +181 +16%
AGM
40
Alpine Global Management
New York
$21K +$29K +1,317 New
BIM
41
BlackRock Investment Management
Delaware
$17K – – –
UBS Group
42
UBS Group
Switzerland
$16K +$22.1K +1,006 New
RCM
43
Rotella Capital Management
Washington
$14K -$18.1K -825 -49%
GC
44
Guggenheim Capital
Illinois
$13K +$18K +820 New
Wells Fargo
45
Wells Fargo
California
$11K -$3.94K -179 -20%
Citigroup
46
Citigroup
New York
$8K +$2.51K +114 +31%
LTFS
47
Ladenburg Thalmann Financial Services
Florida
$6K – – –
Bank of America
48
Bank of America
North Carolina
$3K -$4.68K -213 -53%
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
$2K – – –
BRWM
50
B. Riley Wealth Management
Tennessee
$1K – – –
1
2
3

WINT Hedge Fund Activity: Q4 2014 in Review

56 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q4 2014, worth a combined $59.1M — down 37% from $93.8M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of WINT and 8 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 12 added.

The largest buyer was Millennium Management, adding an estimated $940K. The largest seller was Sphera Funds Management, exiting entirely with an estimated $893K sold.

  • 56 institutional investors held Windtree Therapeutics Inc (WINT) as of Q4 2014, down from 62 in Q3 2014.
  • Funds reported $59.1M of Windtree Therapeutics Inc stock for Q4 2014, down 37% quarter-over-quarter.
  • 8 funds opened new Windtree Therapeutics Inc positions in Q4 2014 and 13 closed out, a net change of -5 holders.
  • The largest Windtree Therapeutics Inc buyer in Q4 2014 was Millennium Management, an estimated $940K added.
  • The largest Windtree Therapeutics Inc seller in Q4 2014 was Sphera Funds Management, an estimated $893K sold.

Based on aggregated 13F filings for Q4 2014.